Big day! Pleased to announce publication of new data describing the mechanism of action of UM171, the molecule that forms the basis of our ECT-001 Cell Therapy! https://t.co/iT5GUwS8Y9

Cancer claims the lives of over 80,000 Canadians a year. @Excellthera is an innovative #Montreal company revolutionizing cancer treatment. Proud to announce with Min @melaniejoly that our federal govt is investing to accelerate their development and growth ! #cdnpoli

Annonce porteuse d’espoir ce matin avec @RachelBendayan. La société de médecine cellulaire & moléculaire @Excellthera reçoit 4M$ pour accroître leur production, sauver encore plus de vies et créer jusqu’à 150 emplois à #Mtl.🙏On renforce notre indépendance en #SciencesdelaVie. 🇨🇦

Une raison de célébrer! On a reçu la classification de produit médicinal de thérapie avancée de @EMA_News pour la thérapie cellulaire ECT-001

Suis à nouveau à la recherche de personnes pour se joindre à des conseils d'administration de startups comme membres indépendant-es. Si ça vous intéresse faites moi signe par message privé ou courriel à mon prénom @realventures.com. Exp sur des CAs similaires un atout important.

Latest data from our study, showing rapid & robust immune recovery in patients transplanted with ECT-001 Cell Therapy, was selected as Best Abstract for oral presentation @CordBloodAssn annual meeting!

We have strengthened our leadership yet again! Pleased to welcome Richard Cherney to our Board of Directors.

Of the 20 engineers on staff at CCRM, 13 are women. Happy #WomenInEngineeringDay to them and the other women engineers around the world breaking down barriers and building bridges - literally.

Our lead solution, ECT-001 Cell Therapy has been granted orphan medicinal product designation by @EMA_News for treatment in haematopoietic stem cell transplantation.

Does anyone in my network have marketing and/or accounting/finance experience and is interested or passionate about esports and gaming? If so, please reach out if you're interested in working together and contributing on an esports project. #esports #gaming #startup

I'm helping out a local esports business get up and running. Anything helps, big or small!

Big news today: a "miracle" in blood stem-cell transplantation, thanks to the #UM171 molecule.

Une molécule miracle. Un bel aperçu de nos progrès. https://t.co/GCpz7suo0c

We are pleased to announce a publication in The Lancet Haematology highlighting excellent clinical results of ECT-001 in patients with haematological malignancies https://t.co/EGfuRjzlc5

ExCellThera annonce la publication dans The Lancet Haematology d’excellents résultats cliniques résultant de l’utilisation d’ECT-001 chez les patients atteints de maladies hématologiques malignes @IRIC_umontreal @UMontreal

See what's developing at ExCellThera. You can now watch our company presentation by Guy Sauvageau, Founder and CEO at the 2019 Cell & Gene Meeting on the Mesa. #Mesa19 https://t.co/FrIHsPP9H3 @alliancerm

Our phase II clinical trial using ECT-001 for high risk leukemia/myelodysplasia in collaboration with Fred Hutchinson Cancer Research Center in Seattle is now recruiting patients. Full trial details:

Nous sommes fiers de continuer de supporter notre société en portefeuille @classcraftgame dans sa transformation du monde de l’education! 👩‍🎓👨‍🎓 Rendez-vous sur @la_lesaffaires pour en savoir plus sur leur dernier financement: https://t.co/phJzmfaX9k

Join our President and CEO, Guy Sauvageau, live or via webcast as he presents a company update at the Meeting on the Mesa on October 2 #Mesa19 https://t.co/WeQkcfHv0z

Great report! Nice to see our lead technology's RMAT designation included as a significant event for the quarter.